for the Period Ended 28 February 2024
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 28 February 2024
Principal activities of the company
Directors
The director shown below has held office during the whole of the period from
1 March 2023
to
28 February 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2024 | 2023 | |
---|---|---|
|
£ |
£ |
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
( |
( |
Profit(or loss) before tax: |
( |
( |
Profit(or loss) for the financial year: |
( |
( |
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Current assets | |||
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: | 3 |
(
|
|
Net current assets (liabilities): |
( |
|
|
Total assets less current liabilities: |
( |
|
|
Total net assets (liabilities): |
( |
|
|
Members' funds | |||
Profit and loss account: |
( |
|
|
Total members' funds: |
( |
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 28 February 2024
Basis of measurement and preparation
for the Period Ended 28 February 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 28 February 2024
2024 | ||
---|---|---|
£ | ||
Other creditors |
|
|
Total |
|
for the Period Ended 28 February 2024
Name of director receiving advance or credit: |
|
Description of the transaction: | |
|
|
£ | |
---|---|
Balance at 28 February 2023 | |
Advances or credits made: |
|
Advances or credits repaid: | |
Balance at 28 February 2024 |
|
The company’s activities during the financial year have had a profound impact on raising awareness and fostering inclusivity within the global community. By documenting and exhibiting diverse conditions and experiences through the art of portraiture, the Brock Elbank Foundation has brought visibility to minority groups and individuals living with rare conditions such as freckles, vitiligo, congenital melanocytic nevus (CMN), alopecia, port wine stains, and scars. This work has celebrated these individuals, promoting body positivity and mental health awareness on an international scale.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
28 November 2024
And signed on behalf of the board by:
Name: Tim David BROCKLEBANK
Status: Director